18.79MMarket Cap-403P/E (TTM)
2.9300High2.7800Low3.06KVolume2.7800Open2.8000Pre Close8.68KTurnover0.06%Turnover Ratio1.06P/E (Static)6.66MShares6.909952wk High0.76P/B13.89MFloat Cap2.610052wk Low--Dividend TTM4.93MShs Float12210.9816Historical High--Div YieldTTM5.36%Amplitude2.6100Historical Low2.8360Avg Price1Lot Size
MEI Pharma Stock Forum
“On October 22, 2024 (the “Closing Date”), MEI Pharma, Inc., a Delaware corporation (the “Company”), and Aardvark Therapeutics, Inc., a Delaware corporation (the “Purchaser”), entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), pursuant to which the Company sold its rights, title and interest in and to certain assets related to ME-...
Wohooo
NEWS
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
MEI Pharma, Inc. reports positive results from the ongoing Phase 1b study of ME-344 in combination with bevacizumab for relapsed metastatic colorectal cancer. 25% of patients had no disease progression at Week 16, exceeding the threshold to add more patients. The combination was well-tolerated, leading to the...
$Gossamer Bio (GOSS.US)$ $Starry Group (STRY.US)$ $Helbiz (HLBZ.US)$ $MEI Pharma (MEIP.US)$ $Digital Brands Group (DBGI.US)$ $Cosmos Health (COSM.US)$ $COMSovereign (COMS.US)$ $Mirati Therapeutics (MRTX.US)$ $United Parcel Service (UPS.US)$ $Sumo Logic (SUMO.US)$
No comment yet